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Abstract
Background: Over the last five decades, a wide gap in mortality opened between western and eastern Europe;
this gap increased further after the dramatic fluctuations in mortality in the former Soviet Union (FSU) in the
1990s. Recent rapid increases in mortality among lower socioeconomic groups in eastern Europe suggests that
socioeconomic factors are powerful determinants of mortality in these populations but the more proximal factors
linking the social conditions with health remain unclear. The HAPIEE (Health, Alcohol and Psychosocial factors In
Eastern Europe) study is a prospective cohort study designed to investigate the effect of classical and non-
conventional risk factors and social and psychosocial factors on cardiovascular and other non-communicable
diseases in eastern Europe and the FSU. The main hypotheses of the HAPIEE study relate to the role of alcohol,
nutrition and psychosocial factors.
Methods and design: The HAPIEE study comprises four cohorts in Russia, Poland, the Czech Republic and
Lithuania; each consists of a random sample of men and women aged 45–69 years old at baseline, stratified by
gender and 5 year age groups, and selected from population registers. The total planned sample size is 36,500
individuals. Baseline information from the Czech Republic, Russia and Poland was collected in 2002–2005 and
includes data on health, lifestyle, diet (food frequency), socioeconomic circumstances and psychosocial factors. A
short examination included measurement of anthropometric parameters, blood pressure, lung function and
cognitive function, and a fasting venous blood sample. Re-examination of the cohorts in 2006–2008 focuses on
healthy ageing and economic well-being using face-to-face computer assisted personal interviews. Recruitment of
the Lithuanian cohort is ongoing, with baseline and re-examination data being collected simultaneously. All
cohorts are being followed up for mortality and non-fatal cardiovascular events.
Discussion: The HAPIEE study will provide important new insights into social, behavioural and biological factors
influencing mortality and cardiovascular risk in the region.
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Background
The rationale for the study
The rationale for this research lies in the intriguing trends
in cardiovascular (CVD) mortality seen in Europe over the
past five decades. While in western Europe total and CVD
mortality have been declining since the 1970s, in Central
and Eastern Europe (CEE) and the former Soviet Union
(FSU) rates have been increasing [1,2]. Dramatic fluctua-
tions in mortality in Russia and other parts of the FSU in
the late 1980s and the 1990s were superimposed on these
long-term trends [3,4]. These trends have resulted in a
large gap in life expectancy between eastern and western
Europe [2,5].
Social factors act at the country (context) level and within
countries. The population level trends provide the con-
text, but it is important to understand how social condi-
tions and lifestyle affect the health of individuals and
groups within countries, rather than to examine trends.
The rise of mortality in unmarried men [6,7], and the
rapid increase in mortality in lower socioeconomic
groups, resulting in dramatic widening of social inequali-
ties within countries of CEE/FSU in recent years [8-14],
suggest a powerful role of social factors. The question is
how they affect cardiovascular disease in these societies
which have undergone profound social change.
Analyses of the WHO MONICA data suggested that classi-
cal risk factors could explain only a part of the temporal
changes and differences between populations [4,15-17].
Similarly, studies within populations, both in the east and
the west of Europe, showed that only part of the socioeco-
nomic differentials in CVD risk were explained by stand-
ard risk factors [18-21]. Other risk factors therefore need
to be considered. Our main hypotheses relate to alcohol,
nutrition and psychosocial factors. Binge and heavy drink-
ing has been proposed as the explanation for the short-
term fluctuations in mortality in Russia [3,22] but the evi-
dence on the contribution of alcohol to trends in mortal-
ity and on the association between heavy and binge
drinking and CVD in individuals remains inconclusive
[23-25]. Nutrition, particularly low consumption of fruits
and vegetables and its biomarkers (such as antioxidant
vitamins or folate), has been linked with CVD risk [26,27]
and has been shown to be low in CEE/FSU [28-31]; how-
ever, direct individual-based evidence on its role in the
high mortality in the region is insufficient. The link
between material hardship and psychosocial distress is
well documented [32] but, again, direct evidence on their
independent effects on CVD in CEE/FSU is sparse. There
is important circumstantial evidence supporting each of
these hypotheses; the ultimate scientific test, however,
requires longitudinal studies of individuals.
Methods and Design
Hypotheses and research questions
To investigate the determinants of cardiovascular diseases
and other chronic conditions in Central and Eastern
Europe, we are conducting a prospective cohort study in
Russia, Poland, the Czech Republic and Lithuania. The
study will investigate the following specific hypotheses:
• Socioeconomic factors are key determinants of health in
CEE/FSU; we will examine the pathways involved in their
action, including factors hypothesised below.
• Psychosocial factors, both at individual and population
level, are related to CVD and other non-communicable
diseases.
• Low consumption of fresh fruits and vegetables and
their nutrient biomarkers are associated with increased
risk of CVD;
• Binge drinking and heavy alcohol consumption are
related to all-cause mortality, CVD and injury;
• Elevated concentration of homocysteine and low levels
of folate and related B vitamins are associated with
increased risk of CVD;
• Interactions between different groups of risk factors, in
particular between heavy drinking and folate deficiency,
and between the MTHFR genotype and folate deficiency,
are associated with CVD.
In addition to these specific hypotheses, the study will
also investigate several more general questions:
• The role of childhood socioeconomic circumstances and
biological markers of their effects, such as leg length and
lung functions, in the risk of CVD and other conditions in
adulthood;
• Biological, social, economic and psychosocial determi-
nants of healthy ageing (cognitive function, physical func-
tioning, and quality of life of elderly persons);
• Genetic predictors and non-conventional biomarkers of
CVD and other chronic diseases.
Study populations and subjects
The HAPIEE (Health, Alcohol and Psychosocial factors In
Eastern Europe) study consists of three cohorts in Novosi-
birsk (Russia), Krakow (Poland) and six centres in the
Czech Republic (Havirov/Karvina, Hradec Kralove, Jihl-
ava, Kromeriz, Liberec and Usti nad Labem). A fourth
cohort is currently being established in Kaunas, Lithuania.BMC Public Health 2006, 6:255 http://www.biomedcentral.com/1471-2458/6/255
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The cohorts consist of random samples of men and
women aged 45–69 years old at baseline, stratified by gen-
der and 5 year age groups, and selected from population
registers. The planned sample size was 10,000 persons in
each country; the actual study size 28,947 individuals
(Table 1). In Russia, both the questionnaire and the exam-
ination have been completed in a clinic. In Poland and
the Czech Republic, the subjects were first visited at home,
to complete a structured questionnaire, and then invited
to a clinic for a short examination. For this reason, not all
subjects have data on both questionnaire and examina-
tion; the proportion of subjects with full data is 82% in
the Czech Republic and 87% in Poland. Lithuania joined
the project in 2005; the planned size of the Lithuanian
cohort is 7,000 men and women aged 45–69 years, ran-
domly selected from the population register of the city of
Kaunas. The study was approved by the ethics committee
at University College London, UK and by the ethics com-
mittee in each participating centre. All participants gave
written informed consent.
Baseline data collection
The baseline survey in Russia, Poland and the Czech
Republic was conducted in 2002–2005; data were col-
lected by structured questionnaires and examination in
clinic including a fasting venous blood sample. The ques-
tionnaire covered health (self-rated health status, medical
history, health behaviours, physical functioning (from the
SF36 instrument)[33,34]; life style, food frequency (in last 3
months), socioeconomic circumstances (own and parental
education; economic status; type of employment; owner-
ship of car and other household items); psychosocial factors
(perceived control [35], the 20 item CESD scale of depres-
sion [36]); quality of life of retired persons (the CASP19
questionnaire) [37]; and psychosocial environment at work
(job demand and job control [38] and effort-reward
imbalance [39,40]). All questions were translated from
English into each language and back translated into Eng-
lish to check for accuracy.
The short examination included measurement of height,
weight, trunk length, waist and hip circumference, blood
pressure, lung function and cognitive function (memory,
concentration and verbal skills). Prior to blood pressure
measurement participants were asked to sit quietly for 5
minutes. Blood pressure was measured three times, with a
two minute interval between measurements, using an
Omron M5-I digital blood pressure monitor. Lung func-
tion was assessed with a Micro-Medical Microplus spirom-
eter (using Spida 4 software to store curves in electronic
format). Forced vital capacity (FVC), peak expiratory vol-
ume in 1 second (PEV1), and peak expiratory flow (PEF)
were recorded. Cognitive function tests involved three
immediate and one delayed recall of 10 words, animal
naming in 1 minute, and letter cancellation in 1 minute.
Blood samples were collected in Becton Dickinson SST II
(10 ml) and K2-EDTA vacutainers (10 ml and 2 × 3 ml).
All vacutainers were stored at 4 degrees Celsius prior to
processing. The 10 ml SST II and 10 ml K2-EDTA vacutain-
ers were centrifuged at 4000 rpm for 15 minutes, and
serum and plasma samples were divided into 4 and 3 aliq-
uots respectively. In addition, one 250 µl aliquot of
plasma was stabilised with 250 µl of 10% metaphos-
phoric acid for subsequent vitamin C determination. The
two 3 ml K2-EDTA vacutainers were not centrifuged; one
vacutainer (destined for glycated haemoglobin determi-
nation) was divided into 2 aliquots × 1.5 ml. All aliquots
were stored in 1.5 ml Sarstedt microtubes, and together
with remaining 3 ml K2-EDTA vacutainer (for DNA extrac-
tion) were stored at -80°C for subsequent laboratory anal-
ysis. DNA has now been extracted, divided into 3 aliquots
and stored at -20°C.
Data entry of baseline questionnaires and medical exami-
nation data in the Czech Republic and Russia was done
using Epi-Info 6 software (CDC, Atlanta, USA), and ques-
tionnaires were electronically scanned in Poland. A pro-
portion of forms were double entered for quality
assurance. Baseline questionnaires in Lithuania are being
completed using CAPI (see re-examination section for
details) and medical examination data is double entered
in Epi-Info 6.
Table 2 summarises the data available from the baseline
survey. All data from questionnaire and examination are
now available. Total cholesterol, HDL cholesterol and
triglycerides have been measured in the Czech Republic,
Poland and Russia. Central laboratory analyses are in
progress for a random sub-sample of 1,000 participants
Table 1: Absolute numbers and response rates in HAPIEE study
Men Women Total Response rate (%)
Russia 4,269 5,094 9,363 61%
Poland 5,230 5,498 10,728 61%
Czech Rep. 4,125 4,731 8,856 55%
Total 13,624 15,323 28,947 59%BMC Public Health 2006, 6:255 http://www.biomedcentral.com/1471-2458/6/255
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per country (including determination of folate, vitamin
B12, homocysteine, glycated haemoglobin, vitamin C,
alfa-tocopherol, beta-carotene, retinol and C-reactive pro-
tein). Baseline examination of the Lithuanian cohort
began in Spring 2006 and is expected to be completed by
summer 2008.
Re-examination of the cohorts
Re-examination of the cohorts started in spring 2006 and
is planned to take 2 years in all four countries. The main
focus of the re-examination is healthy ageing and eco-
nomic well-being. The data are being collected by face-to-
face Computer Assisted Personal Interview (CAPI) using
Blaise 4.6 software (Statistics Netherlands). The generic
version of the CAPI program is in English, but all ques-
tions have been forward and backward translated into
each language to ensure consistency of questions in all
countries.
The ageing-related outcomes include: cognitive functions
(as in baseline); physical functioning (12 items from SF-
36 questionnaire [33,34]; activities of daily living (ADL),
instrumental activities of daily living (IADL), walk speed,
chair rise and grip strength; quality of life (12-item CASP
questionnaire[37,41] and social participation. The walk
speed test records the time to walk a distance of 2 m at
usual speed, while the chair rise test records the time to
stand up and sit down 5 times without using their arms. A
Scandidact dynamometer is used to measure the maxi-
mum grip strength of each hand.
The  economics  measures include details on retirement;
household composition; formal and informal household
income; household wealth; and expectations of future
pensions. Table 2 summarises the data being collected
during re-examination of the cohort. In Lithuania, base-
line data collection and collection of additional data on
healthy ageing and economic well-being will be collected
simultaneously. The re-examination has been designed in
such a way that the data on ageing and economics will be
directly comparable with the English Longitudinal Study
of Ageing [42], the Study of Healthy Ageing and Retire-
ment in Europe (SHARE) [43], and Health and Retire-
ment Study (HRS) in the USA [44].
Follow up of the cohorts
The study has two primary outcomes of interest: a) mor-
tality from all causes and from CVD, and b) non-fatal car-
diovascular events. Over the last year, the follow-up
mechanisms for these outcomes have been piloted.
Mortality
We use the following data sources on mortality. In Nov-
osibirsk, we use the death register developed by the Insti-
tute of Internal Medicine. The register is based on data
from medical death certificates, the Novosibirsk office of
the State Statistical Bureau (Goscomstat) and from the
population registration bureau (ZAGS). The system has
been in place for a number of years and provides complete
coverage of deaths in the study population [18,24]. In
Krakow, we use the provincial death register covering the
city of Krakow and surrounding area. In the Czech Repub-
lic, we use the national death register. In Lithuania, we use
the Kaunas regional mortality register. In the past, the reg-
ister has been shown to provide a complete coverage of
deaths in Kaunas [45].
Non-fatal cardiovascular events
The availability of data on non-fatal cardiovascular events
differs by country. In Russia and in Lithuania, there are
existing registers of myocardial infarction (MI) and stroke
established by the WHO MONICA Project [46], but not in
Poland and the Czech Republic. In order to obtain com-
parable data in all four countries, we piloted the mecha-
nisms to (1) identify, (2) confirm and (3) validate
incident non-fatal cardiovascular events.
(1) Identification
Postal questionnaire is the primary source for identifying
cases in all 4 countries. The questionnaire was sent out in
spring 2005 and 2006, will be repeated during the cohort
re-examination in 2006–2008 and will then be sent by
post every 3 years. Potential CHD cases are identified by
positive responses to questions on history of MI, cardiac
procedures or history of stroke. To identify events for non-
responders to the postal questionnaire and re-examina-
tion phase, we will use the MI and stroke registers in Rus-
sia and Lithuania, and hospital databases in the Czech
Republic (and hopefully in Poland). The proportion of MI
cases identified by questionnaire and by these other
sources will be compared in order to estimate the poten-
tial loss of cases in countries without registers.
(2) Confirmation
Potential incident cardiovascular events (MI, unstable
angina and stroke, or diagnostic or therapeutic procedures
such as angioplasty or CABG), identified from data
sources described above, will be validated using the fol-
lowing information: discharge reports and hospital/med-
ical records. If the discharge report indicates a potentially
acute incident coronary event, further information on
signs, symptoms and enzymes, and copies of ECGs are
sought from hospital records, to enable validation of hos-
pital diagnosis and application of different MI criteria.
Prevalent cardiovascular events will not undergo full vali-
dation but we plan to obtain hospital discharge data
wherever possible to increase the accuracy of the baseline
data. For stroke cases, discharge and/or hospital reports
are collected on each episode of stroke identified by the
postal questionnaire and by stroke registers in Russia andBMC Public Health 2006, 6:255 http://www.biomedcentral.com/1471-2458/6/255
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Table 2: Overview of questionnaire and medical examination data available in the HAPIEE study
Domain Variables Wave I (Baseline) Wave II
Health Medical history Y Y
Current medication Y Y
Self-rated health Y Y
Alcohol, pattern & problem drinking Y Y
Awareness & treatment of high BP, high cholesterol and diabetes Y Y
Depression (CESD-20) Y -
Depression (CESD-10) - Y
Injuries in last year Y Y
Food frequency (fruit & vegetable intake, seasonality) Y -
Expectations of future health and length of life - Y
Anthropometry (height, weight, waist and hip circumference, and sitting height) Y -
Blood pressure Y -
Heart rate Y -
Pulmonary functions (FVC, FEV1 and PEF) Y -
Blood sample Y -
Physical functioning Physical functioning (from SF36) Y Y
ADL & IADL - Y
Walk speed - Y
Chair rise - Y
Grip strength - Y
Cognitive functions Memory (immediate and delayed word recall) Y Y
Concentration Y Y
Speed Y Y
Numeracy - Y (LT only)
Social status Education Y Y
Marital status Y Y
Childhood social circumstances Y Y
Brief employment history Y Y
Self-assessed material deprivation Y YBMC Public Health 2006, 6:255 http://www.biomedcentral.com/1471-2458/6/255
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Life-grid of past social status - Y
Housing conditions/crowding - Y
Psychosocial factors Social networks Y Y
Perceived control over life Y Y
Job control/demand (working only) Y -
Effect/reward imbalance (working only) Y Y
Social participation Y Y
Happiness - Y
Economics Household amenities Y Y
Current economic activity Y Y
Current labour market status Y Y
Personal income - Y
Household income and wealth - Y
Housing tenure - Y
Benefits - Y
Informal transfers - Y
Non-monetary income - Y
Self-production - Y
Expectations of future economic position - Y
Retirement Type of retirement - Y
Reasons for retirement - Y
Quality of life CASP-19 (retired only) Y -
CASP-12 (all participants) - Y
Community-level Social trust Y Y
characteristics Perception of reciprocity - Y
Membership in civil organizations - Y
Collective efficacy - Y
Area characteristics from official sources - Y
Legend Y = yes; CESD = Center for Epidemiological Studies – Depression scale ; FVC = forced vital capacity; FEV1 = forced expiratory volume in 1 
second; PEF = peak expiratory flow; ADL = activities of daily living; IADL = instrumental activities of daily living; LT = Lithuania; CASP = Control, 
Autonomy, Self-realization and Pleasure.
Table 2: Overview of questionnaire and medical examination data available in the HAPIEE study (Continued)BMC Public Health 2006, 6:255 http://www.biomedcentral.com/1471-2458/6/255
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Lithuania, to provide the rates of clinically confirmed
strokes, and allow comparison between countries.
(3) Validation
We will use a simplified version of the criteria developed
by the American Heart Association [47]. We are collecting
an extensive range of data on each event, including signs,
symptoms, biomarkers (including non-troponin
enzymes) and, where possible, at least 3 copies of ECG.
This will allow us to apply different sets of criteria, includ-
ing those less stringent than AHA, such as the MONICA
criteria [46]. Stenosis of more than 70% in any artery or
50% in left main artery, PCI, and CABG are considered as
indicating CHD.
Statistical analysis
On the basis of the follow up conducted so far, we esti-
mate that by the end of 2008 and 2010, i.e. on average 4
and 6 years after the baseline survey, there will be a total
of about 1360 and 2180 deaths, respectively, from all
causes across the three existing cohorts (without Lithua-
nia), approximately half of them from CVD. In terms of
non-fatal events, we estimate that by the end of 2009
(postal CVD questionnaire will be repeated in spring
2010) there will be approximately 750 new coronary
events and approximately 350 new strokes. These num-
bers will provide the study with sufficient statistical power
to analyse the relationship between proposed risk factors
and mortality and non-fatal events and thus to test the
research hypotheses.
Baseline data are currently being analysed, but the main
hypotheses will be tested using the longitudinal data.
After initial exploratory analyses, age-adjusted effects will
be estimated by Cox proportional hazard modelling, sep-
arately for each country and separately for men and
women. These estimates will provide the first estimates of
the effects of the independent factors and will show
whether there could be effect modification by (heteroge-
neity between) sex and country. Possible clustering of sub-
jects within cities will be taken into account. Multivariate
Cox regression models will be used to estimate independ-
ent effects of the suspected risk factors, taking into
account potential confounders and effect modifications.
Possible pathways linking risk factors with the outcome
will be set out a priori, and associations and pathways will
be confirmed by structural equation modelling. In addi-
tion, data from baseline and re-examination will be used
to assess changes in risk factors over time (e.g. smoking,
heavy drinking) and intermediate health characteristics
(presence of diabetes, hypertension or angina).
The analyses will focus on data from the HAPIEE cohorts
but in some instances, comparisons with western popula-
tions will be important. There are several such compari-
son groups. First, we have access to data from a small
cohort (n = 1007, the same age groups as HAPIEE cohorts)
set up in 2003 in southern Sweden under direction of Dr
Margareta Kristenson, University of Linkoping, using a
similar protocol and many identical measurements. Sec-
ond, we will compare psychosocial determinants of mor-
bidity and mortality with the Heinz Nixdorf-RECALL
study [48]. Third, we will use data from Whitehall II study
of civil servants [49] with identical measurements of
many lifestyle and psychosocial factors. Fourth, we have
access to data from the English Longitudinal Study of Age-
ing [42], housed in the UCL Department of Epidemiology
and Public Health, with measurements of ageing related
outcomes and economics identical to those in the HAPIEE
study.
Discussion
The HAPIEE study will provide valuable insight into the
determinants of CVD and other chronic conditions in
Eastern Europe and the former Soviet Union where health
and mortality have worsened dramatically over a very
short period, coinciding with transition from commu-
nism to market economy. Such societal transition is often
accompanied by a rapid increase in social inequalities and
social distress. Currently the understanding of trends in,
and determinants of, health in such societies is patchy at
best. The results from HAPIEE study will be relevant for
policies aiming to alleviate the impact of transition in
other populations.
This large cohort study with extensive measurements and
a rich bank of biological and genetic samples will be used
to test both existing and new hypotheses concerning
causes of disease and ill health to confirm that associa-
tions between risk factors and disease seen in the west can
be replicated in non-western populations. It will investi-
gate the social patterning of health and, because the social
structure differs from the west, will increase understand-
ing of the links between social environment and health.
The current focus on healthy ageing is important, since
age-related onset of disability in Russia seems faster than
in the west [50,51] but so far little is known about the
determinants of health among the elderly in Eastern
Europe.
The most serious challenge in this study was to achieve
satisfactory response rates. Our projection of the study
size of 30,000 persons was based on response rates in ear-
lier studies in Eastern Europe in the late 1990s but
response rates in the region have since declined rapidly.
Although our final response rates are typical for current
studies in Eastern Europe, and elsewhere [52-56], careful
assessment of the non-response bias is nevertheless
important. In all centres, we collected short question-
naires from sub-sample of those who refused participa-BMC Public Health 2006, 6:255 http://www.biomedcentral.com/1471-2458/6/255
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tion. In Novosibirsk and Krakow, we conducted extra
home visits in a sub-sample of non-respondents; in the
Czech Republic we assessed the completeness of the pop-
ulation registers in the Czech town with the largest
number of invitations. The analysis of these data and the
comparison of participants and non-respondents showed
two important features.
First, a non-negligible proportion of non-respondents had
moved away or died before the start of the study and were
therefore not eligible for the study. Extrapolating from the
proportion of incorrect addresses identified in home visits
in Krakow and Novosibirsk and from the assessment of
the accuracy of the population register, the real response
rates are higher than those shown in Table 1 – at least 68%
in Krakow, at least 71% in Novosibirsk and over 60% in
the Czech Republic. A further proportion of non-respond-
ents could not be contacted after 3 home visits, and many
of these may not live at their officially registered address.
The true response rates may therefore be even higher.
Second, participation rates were higher in women,
increased with age, and participants had higher education,
better self-rated health and lower prevalence of smoking
than non-respondents. This confirms the general experi-
ence that responders in epidemiological studies are
healthier than non-responders [57]. Response rates and
healthy volunteer bias may complicate comparisons
between cohorts but they will not have a large influence
on within cohort analyses.
The HAPIEE study is one of the largest prospective studies
of non-communicable diseases ever conducted in Eastern
Europe, and it is one of the first that will systematically
investigate healthy ageing and its determinants. The
results of the study will provide important insights into
social, behavioural and biological risk factors of cardio-
vascular diseases, injuries, depression and other condi-
tions common in the region.
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